The Mental Health Clinician Seeks Quality Manuscripts

The MHC Editorial Board is actively seeking manuscripts on the topics below. While we may not be able to include all interested authors, we hope to highlight the best our membership has to offer. Submissions will undergo peer-review and consideration for publication upon meeting the journal’s criteria (review the author guidelines).

  • Psychiatric Medication Use in Special Populations: This issue of The Mental Health Clinician will include manuscripts that focus on meeting the psychiatric pharmacotherapy needs of uniquely complex patient populations. Special populations of interest may include patients unable to receive medications by mouth, patients who have undergone gastric bypass or sleeve gastrectomy surgery, patients with severe hepatic or renal disease, as well as other clinically complex patient populations. Original research manuscripts will receive priority but high-quality case reports, literature reviews, and medication-use evaluations are also welcomed. Please contact Dan McGraw at dan.mcgraw42@gmail.com to express interest.
  • Controversies in Practice: This issue will include topics that may be deemed controversial in clinical psychiatric and/or neurologic practice. Manuscripts may be submitted as case reports, literature reviews, or original research. Example submissions for consideration include:  place in therapy of ketamine for MDD; the use of TCAs in patients with suicidal ideation; safety of melatonin in children; and application of pharmacogenetic testing. Other ideas are welcome, and original research will receive priority. Contact etill2020@gmail.com.
  • Innovations in Psychopharmacology: This issue of The Mental Health Clinician will include manuscripts that focus on new psychiatric pharmacotherapy (e.g. newly approved agents/indications/formulations) or new approaches to treatment (e.g. genetic testing, therapeutic drug monitoring) that have emerged in the past five years. Original research manuscripts will receive priority but high-quality case reports, literature reviews, and medication-use evaluations are also welcomed. Please contact Troy Moore at mode101troy@gmail.com to express interest.
  • Other Topics: If you have an interesting poster or manuscript that does not align with any of those topics, please consider an open submission to the MHC. To learn more about open submissions and the MHC processes in general, review the MHC author guidelines. If you want to confirm whether a particular open submission is likely to be considered, you can email your abstract to mhc@cpnp.org for feedback.
Contact DeadlineProject StatusProposed AcknowledgementPositions AvailableMore Information
05/12/17MHC Issue PlanningPrimary Author Credit-view